- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- December 2024
- 175 Pages
Global
From €4410EUR$5,000USD£3,817GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €2646EUR$3,000USD£2,290GBP
- Drug Pipelines
- April 2025
- 450 Pages
Global
From €4410EUR$5,000USD£3,817GBP
- Drug Pipelines
- April 2025
- 40 Pages
Global
From €1102EUR$1,250USD£954GBP
- Clinical Trials
- April 2025
- 120 Pages
Global
From €2646EUR$3,000USD£2,290GBP
- Clinical Trials
- April 2025
- 150 Pages
Global
From €2205EUR$2,500USD£1,909GBP
- Clinical Trials
- April 2025
- 100 Pages
Global
From €1764EUR$2,000USD£1,527GBP
- Drug Pipelines
- April 2025
- 120 Pages
Global
From €1764EUR$2,000USD£1,527GBP
- Drug Pipelines
- April 2025
- 230 Pages
Global
From €2646EUR$3,000USD£2,290GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2205EUR$2,500USD£1,909GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2646EUR$3,000USD£2,290GBP
- Drug Pipelines
- April 2025
- 150 Pages
Global
From €2205EUR$2,500USD£1,909GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1764EUR$2,000USD£1,527GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1764EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2205EUR$2,500USD£1,909GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1764EUR$2,000USD£1,527GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more